Success stories of Palestinian achievers from all over the world

Amal Ghaleb Al-Bakri

Personal Info

  • Country of residence: Jordan
  • Gender: Female
  • Born in: 1971
  • Age: 50
  • Curriculum vitae :

Information

Amal Ghaleb Al-Bakri
Professor of Pharmaceutical Microbiology
Department of Pharmaceutics and Pharmaceutical Technology
Faculty of Pharmacy/ The University of Jordan
Queen Rania St.
Amman, 11942 Jordan
Personal Information
Name: Amal Ghaleb Al-Bakri
Date of Birth: 23, September, 1971
Nationality: Jordanian
Current Address: Department of Pharmaceutics and Pharmaceutical Technology
Faculty of Pharmacy, The University of Jordan
Amman, 11942 Jordan
Tel: +962 6 5355000 ext-23330
Fax: +962 5 339649
Email: agbakri@ju.edu.jo
www.ju.edu.jo/sites/academic/agbakri
Education
1989
1993-1994
Secondary School Certificate, Tawjihi (Excellent, 93.8)
Rosary College, Amman-Jordan
B.Sc. in Pharmacy (Excellent, 2/120)
Faculty of Pharmacy, The University of Jordan, Amman, 11942 Jordan
1999-2001 Ph.D. in Pharmaceutical Sciences / Microbiology, Thesis title:
" Co-Culture of Pseudomonas aeruginosa and Burkholderia cepacia:
Implications to Cystic Fibrotic Lung Infection"
Faculty of Medicine, Dentistry, Nursing and Pharmacy
School of Pharmacy and Pharmaceutical Sciences
The University of Manchester, Oxford Road, Manchester UK M13 9PL
Training and Working Experience
1994-1997 Teaching Assistant. Faculty of Pharmacy, The University of Jordan,
Amman-Jordan.
1997-2001 Ph.D. student. Faculty of Medicine, Dentistry, Nursing and Pharmacy.
School of Pharmacy and Pharmaceutical Sciences. Manchester, U.K.
2002-2007 Assistant Professor. Department of Pharmaceutics and Pharmaceutical
Technology, Faculty of Pharmacy, The University of Jordan, Amman-
Jordan.
2007-2012 Associate Professor. Department of Pharmaceutics and Pharmaceutical
Technology, Faculty of Pharmacy, The University of Jordan, Amman-
Jordan.
2004-2007 Dean Assistant for Academic Development. Faculty of Pharmacy, The
University of Jordan, Amman-Jordan.
2004-2005 Preparation of Program Specification and Self Assessment Documents for
the Faculty of Pharmacy, The University of Jordan, Amman, Jordan.
2007- Sep 2011 Vice Dean. Faculty of Pharmacy, The University of Jordan, Amman,
Jordan.
2007- Sep 2011
2012-current
2013-2014
Head of Committee for Postgraduate Studies
Professor. Department of Pharmaceutics and Pharmaceutical Technology,
Faculty of Pharmacy, The University of Jordan, Amman-Jordan.
Dean. Faculty of Pharmacy, The Royal University for Medical Sciences,
Amman-Jordan
Research Interests
1. Microorganisms as Planktonic and Biofilm cultures: Their growth characteristics and control.
2. Drug Discovery: Identification and testing of new compounds including natural products as
potential antibacterial and antipathogenic agents (Quorum sensing inhibitors and anti adhesion
agents). In collaboration with researchers from the Faculty of Pharmacy and Faculty of Science-
University of Jordan.
3. Molecular characterisation of resistant strains of Staphylococcus aureus and Acinetobacter
baumannii and their prevalence within the Jordanian population. In collaboration with researchers
from the Faculty of Pharmacy and the Faculty of Medicine-University of Jordan.
4. Community drug use and abuse and rationale drug use in Jordan's health care system.
5. Photodynamic antimicrobial chemotherapy PACT and its use in pharmaceutical dosage forms to
control microbial infections.
Research Funding/Grants
Sep, 2003 1. Antibiotic resistance surveillance in Jordan. (Deanship of Academic Research,
University of Jordan, 7, 350 $). Publication no.4.
Dec, 2003 2. Testing of Protein Tyrosine phosphatase (PTPase) inhibitors captured by in-silico
screening as potential new hypoglycemic agents. (Deanship of Academic
Research, University of Jordan, 14, 400 $).Publication no. 5.
Nov, 2004 3. Testing of non-nucleoside compounds predicted by computer pharmacophore
modeling of HIV type-1 reverse transcriptase inhibitors as novel anti-Human
Immunodeficiency Virus (AIDS). (Deanship of Academic Research, University of
Jordan, 24, 500 $). Publication no.13.
Sep, 2006 4. Search for new potent antibacterial agents via ligand-based and structure-based
modeling techniques followed by microbiological validation. (Deanship of
Academic Research, University of Jordan, 26, 700 $). Publication no. 10.
2007 5. Biofilm formation and eradication of methicillin and vancomycin resistant
staphylococci isolated from Jordanian community. (Deanship of Academic
Research, University of Jordan, 21, 780 $). Manuscript is under preparation.
2009 6. Molecular categorization, epidemiological surveillance and virulence determinants
of methicillin resistant Staphylococcus aureus (MRSA) and coagulase-negative
staphylococcus (CoNS) in Jordanian community. (Scientific Research Fund,
Ministry of Higher Education, 44, 975 $). Manuscript is under preparation.
2010 7. Pilot study for the in vitro evaluation of antimicrobial activity of Varthemia
iphionoids Boiss (family Compositae) crude extracts in the treatment of topical
skin bacterial and fungal infections.
(The National Center for Biotechnology, 5, 421 $).
2010 8. Formulation and Evaluation of Pharmaceuticals containing photosensitizers as
novel antimicrobial agents.(The National Center for Biotechnology, 22, 480 $).
2010 9. Staff Exchange Scheme FP7 2010 ( 32, 000 EUR).
2011
2012
2014
2014
10. Daniel Turnber Fellowship for Medical Sciences Award (3, 500 £).
11. Study of prevalence and risk factors associated with diabetic foot infections caused
by MRSA among Jordanian patients. (Deanship of Academic Research, University
of Jordan, 20600 JD)
12. Screening of antimicrobial and antiquorum sensing activity in macro algae from
Gulf of Aqaba, Red Sea. (Deanship of Academic Research, University of Jordan)
13. Co-culture of Pseudomonas aeruginosa biofilm on cultured cystic fibrosis airway
cells. (Deanship of Academic Research, University of Jordan)

Publications
1. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (1999). Mixed species biofilms of
Burkholderia cepacia and Pseudomonas aeruginosa. Biofilms, The Good, The Bad and the Ugly
pp327-337. Edited by Wimpeny, J, Gilbert, P, Walker, J, Brading, M and Bayston R. Bioline:
Cardiff.
2. A.G. Al-Bakri, P. Gilbert and D.G. Allison (2004). Immigration and emigration of Burkholderia
cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. Journal
of Applied Microbiology 96, pp 455-463.
3. Amal G. Al-Bakri, Peter Gilbert, David G Allison (2005). Influence of gentamicin and
tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas
aeruginosa. Journal of Basic Microbiology. 45 (5), pp 392-396.
4. Amal G. Al- Bakri, Yasser Bustanji, Al-Motassem Yousef (2005). Common consumption of
antibacterial drugs within the Jordanian population: sources, patterns and appropriateness.
International Journal of Antimicrobial Agents. 26, pp 389-395.
5. Yasser Bustanji, Mutasem O. Taha, Al-Motassem Yousef Amal G. Al- Bakri (2006). Berberine
potently inhibits protein tyrosine phosphatase 1B: Investigation by docking simulation and
experimental validation. Journal of Enzyme Inhibition and Medicinal Chemistry. 21 (2), pp 163-
171.
6. Mutasem O. Taha, Amal G Al-Bakri Waleed Zaloum (2006). Discovery of potent inhibitors of
Pseudomonal quorum sensing via pharmacophore modeling and in-silico screening. Journal of
Bioorganic and Medicinal Chemistry Letters. 16(22), pp 5902-5906.
7. Amal G Al-Bakri and Fatima Afifi (2007). Evaluation of antimicrobial activity of selected plant
extracts by rapid XTT colorimetry and bacterial enumeration. Journal of Microbiological
Methods. 68(1), pp 19-25.
8. Mutasem O. Taha, Yasser Bustanji, Amal G. Al-Bakri. Al-Mottasem Yousef, Waleed A.
Zalloum, Ihab Al-Masri, and Naji Atallah (2007). Discovery of new potent human protein
tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in-silico
screening. Journal of Molecular Graphics and Modeling. 25(6), pp 870-884.
9. Yousef A.M. Al-Bakri A.G., Yasser Bustanji, Al-Wazaify M. Self Medication Patterns in
Amman, Jordan (2008). Pharmacy World and Science. 30(1), pp 24-30.
10. Taha MO, Atallah N, Al-Bakri A.G., Paradis-Bleau C, Zalloum H, Younis KS, Levesque RC
(2008). Discovery of new MurF inhibitors via pharmacophore modelling and QSAR analysis
followed by in-silico screening. Bioorganic and Medicinal Chemistry. 16(3), pp 1218-1235.
11. Al-Bakri A.G., Othman, G and Bustanji Y (2009). The assessment of the antibacterial and
antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as
antibiofilm agents. Journal of Applied Microbiology 107(1), pp 280-286.
12. Al-Momany NH, Al-Bakri AG, Makahleh ZM, Wazaify MMB (2009). Adherence to
international antimicrobial prophylaxis guidelines in cardiac surgery: a Jordanian study
demonstrates need for quality improvement Journal of Managed Care Pharmacy. 15 (3), pp 262-
271.
13. Bustanji Y, Al-Masri IM, Qasem A, Al-Bakri AG and Taha MO (2009). In silico screening for
non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and highthroughput
docking followed by in vitro evaluation. Chemical Biology and Drug Design, 74 (3),
pp 258-265.
14. Saadeh, HA, Mosleh IM, Al-Bakri AG and Mubarak MS (2010). Synthesis and antimicrobial
activity of new 1,2,4-triazole-3-thiol metronidazole derivatives. Monatshefte für Chemie, 141, pp
471-478.
15. Al-Bakri AG, Othman G and Afifi FU (2010). Determination of the antibiofilm, antiadhesive
and anti-MRSA activities of seven Salvia species. Pharmacognosy Magazine, 6, pp 264-270.
16. Taha MO, Qandil AM, Al-Haraznah T, Khalaf RA, Zalloum H, Al-Bakri AG (2011). Discovery
of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl
transferase inhibitors followed by in silico screening. Chemical Biology and Drug Design, 78(3),
pp 391-407.
17. Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S (2011). Docking-based
Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for
validating docking studies and in silico screening: NMT and GP inhibitors as case studies. Journal
of Chemical Information and Modeling, 51(3):647-669.
18. Haythem A. Saadeh, Eman A. Abu Shaireh, Ibrahim M. Mosleh, Amal G. Al-Bakri and
Mohammad S. Mubarak (2011). Synthesis, characterization and biological activity of Schiff bases
derived from metronidazole. Medicinal Chemistry Research. DOI: 10.1007/s00044-011-9830-y. Online
19. Mohammed H. Kailani, Amal G. Al-Bakri, Haitham Saadeh and Yusuf M. Al-Hiari.
Preparation and anantimicrobial screening of novel 2,2-dichloropropane-cis-dicarbamates and
comparison to their alkane and cis alkene analogs. (2012). Jordan Journal of Chemistry, 7(3):
20. A.G. Al-Bakri, H Al-Hadithi, V. Kasabri, G. Othman, A. Kriegeskorte and K. Becker. The
epidemiology and molecular characterization of methicillin-resistant staphylococci sampled from
healthy Jordanian population (2013). Epidemiology and infection, 23: .1-8.
21. Asem A Shehabi Rozan Abu-Yousef, Eman Badran, Amal G. Al-Bakri, Luay Abu-Qatouseh
and Karsten Becker. Major Characteristics of Staphylococcus aureus colonizing Jordanian infants
(2013). Pediatrics International. 55(3):300-4. doi: 10.1111/ped.12060.
22. Obeidat N, Jawdat F, Al-Bakri AG ,Shehabi AA. Major biologic characteristics of Acinetobacter
baumannii isolates from hospital environmental and patients' respiratory tract sources (2014).
American Journal of Infect Control. 42(4):401-4. doi: 10.1016/j.ajic.2013.10.010.
23. Adwan S1, Abu-Dahab R, Al-Bakri AG, Sallam A. Glyceryl monooleate-based otic delivery
system of ofloxacin: release profile and bactericidal activity (2014). Pharmaceutical Development
and Technology. Jan 6 (doi:10.3109/10837450.2013.871030).
24. Amjad M. Qandil, Lorca O. Al-Zoubi, Amal G. Al-Bakri, Haneen A. Amawi , Qosay A. Al-Balas
,Abdulmalik M. Alkatheri and Abdulkareem M. Albekairy. Synthesis, Antibacterial Evaluation and
QSAR of α-Substituted-N4-Acetamides of Ciprofloxacin and Norfloxacin (2014). Antibiotics. 3(3),
244-269; doi:10.3390/antibiotics3030244
25. Safa Daoud, Fatma U Afifi, Amal G Al-Bakri, Violet Kasabri, and Imad I Hamdan. Preparation
Physicochemical Characterization and Biological Evaluation of some Hesperidin Metal Complexes
(2014) Iran J Pharm Res. 13(3): 909–918.
26. Malath A. Al-Qtaitat, Haythem A. Saadeh, Amal G. Al-Bakri, Hargobinder Kaur, Kapil Goyal,
Rakesh Sehgal, Mohammad S. Mubarak. Synthesis, characterization, and biological activity of
novel metronidazole-piperazine amides (2014). Monatsh Chem. DOI 10.1007/s00706-014-1352-0
27.
Supervision: M.Sc. and Ph.D Projects
1. Generation of an optimal pharmacophoric model for quorum sensing agonists and
antagonists in Pseudomonas aeruginosa employing ligand based technique and
subsequent experimental validation. (Defended on January 2006). Publication no.6.
2. Composition of Jordanian rosemary and fennel essential oils and their antimicrobial
effects against four major foodborne bacterial pathogens. (Defended on December, 2006)
3. Docking, CoMFA and pharmacophore modeling of the MurB enzyme inhibitors for the
discovery of new selective anti-bacterial agents and subsequent experimental validation
(Defended on May, 2007). Publication no. 10.
4. Comprehensive study of the use of prophylactic antibiotics in clinical practice in cardiac
surgery in Jordan: microbiological study of normal flora and surgical site infecting
organism, adherence to international guidelines, and obstacles against adherence
(Defended on July, 2007). Publication no. 12.
5. The assessment of the anti-adhesive and anti-biofilm activities of selected agents towards
the establishment of pseudo steady-state microbial biofilms on abiotic surfaces and their
potential use as catheter lock therapy (Defended on April, 2008). Manuscript is under
preparation.
6. Pharmacophore modelling of Enterococcus faecalis Fab H enzyme inhibitors for the
discovery of new selective anti-bacterial agents and subsequent experimental validation
(Defended on August, 2008).
7. Discovery of new Candida albicans protein N-myristol transferase (NMT) inhibitors via
novel structure based molecular modeling approach followed by experimental validation
(Defended on July, 2010). Publication no.17.
8. Preparation and antimicrobial evaluation of 7-substituted aniline-8-nitrofluoroqunolones
(Defended on August, 2010).
9. A Prospective randomized controlled trial to investigate the impact of a Clinical
pharmacist on treatment-related problems in patients who receive anti-infective therapy in
the general intensive care unit (ICU) ward of a major medical centre in Jordan (Defended
on November, 2010).
10. The assessment of biofilm formation of Acinetobacter baumannii isolates from human
and environment sources in association with antimicrobial resistance (Defended on
December, 2010). Publication no 22.
11. Studying the effect of specific wave length light-activation of photosensitizer-Pluronic gel
based topical formula against Staphylococcus aureus culture (Defended on May, 2012).
12. Preparation and characterization of microemulsion based formula of 5-aminolaevulinic
acid (ALA) photosensitizer for PACT treatment of acne. (Defended on May, 2014)
13. Cross sectional evaluation of the usage of the broad spectrum intravenous antibiotics in
the JUH intensive care units. (Defended on May, 2014).
14. The Effect of Iberin against Pseudomonas aeruginosa biofilms on cultured cystic fibrosis
airway cells. (Ph.D project, 2014)
A member in the examination committee of Postgraduates
1. The prevalence of adhesion (ica D and fib) and toxin (tst, eta and etb) genes in Jordanian
Staphylococcus aureus isolates (July, 2004).
2. Antibiotic self-medication among health professional students at Jordan University (January.
2007).
3. The immunomodulatory effect of Gemifloxacin on human peripheral mononuclear blood cells
(August, 2009).
4. Immunogenicity evaluation of an erythropoietin product in patients with chronic renal failure
(August 2010).
5. Preparation, Physicochemical characterization and biological evaluation of some hesperidin metal
complexes (August, 2010).
6. Assessment of the antirheumatic activity of Salvia fruticosa Mill (Syn: Salvia triloba L. Fil)
(Lamiaceae); by performing enzymatic, cellular and in vivo studies (June, 2011).
7. Evaluation of prolonged intermittent fasting effect on immune system and some blood
inflammatory cytokines in healthy volunteers (April, 2011).
And others
Conferences and Talks Attended
1. Biofilms: Community Interactions and Control (1997). Cardiff, U.K.
2. Biofilms: The Good, the Bad and the Ugly (1999). Cardiff, U.K.
3. Society for General Microbiology Symposium on Microbial Signalling and Communication
(1999). Edinburgh, U.K.
4. American Society for Microbiology Conference on "Biofilms 2000" (2000). Big Sky, Montana,
USA.
5. Society for General Microbiology Symposium on Community Structure and Co-operation in
Biofilms (2000). Exeter, U.K.
6. Biofilm Community Interactions: Chance or Necessity? (2001). Cardiff, U.K.
7. The 2nd Arabian Symposium of Antibiotics (2002). Damascus, Syria.
8. The 2nd International Conference of the Royal Jordanian Medical Services (2003). Amman, Jordan.
9. Faculty of Pharmacy Symposium "Advanced Computer Aided Drug Discovery Techniques
Adopted at the Faculty of Pharmacy-The University of Jordan" (2003). Amman, Jordan.
10. The 3rd Arab Symposium for Antimicrobial Agents "Towards Rational use of Antimicrobials
(2004). Dar El Defaa El Gawi, Cairo, Egypt.
11. The 3rd International Conference of the Royal Medical Services in Collaboration with the Royal
college of Physicians of London (2006). Amman, Jordan.
12. The 4th Arab Symposium for Antimicrobial Agents (2006). Tunis, Tunis.
13. USP 2nd Regional Scientific Workshop (9-10, September, 2006). Amman, Jordan.
14. The 2nd Jordanian Workshop "Synchrotron Light for Experimental Science and Applications in
the Middle East [SESAME] in Research, Training and Technological Applications" (September,
2006). Amman, Jordan.
15. Sterilizing Filters Validation Issues: Today and the Future. Pall Italia & Pall Middle East.
(15 November, 2006). Amman, Jordan.
16. USP 2nd Regional Scientific Workshop (9-10, September, 2006). Amman, Jordan.
17. The 9th International Conference on Biology and Synchrotron Radiation (13-17, August, 2007).
Manchester, UK.
18. The 6th Arab Conference of Antimicrobial agents (16-18, October, 2008). Rabat, Morocco
19. The 7th Arab Conference of Antimicrobial agents (2009). Lebanon, Beirut.
20. The 8th A Arab Conference of Antimicrobial agents (2010). Syria ,
21. The Third conference of the Federation of Arab Societies of Clinical Microbiology and
Infectious diseases and the Tenth Conference of Arab Alliance for Prudent Use of Antimicrobial
Agents. 2014. Amman-Jordan
Conferences: Podium Presentations
1. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (1999). Mixed species biofilms of
Burkholderia cepacia and Pseudomonas aeruginosa. Biofilms: The Good, the Bad and the
Ugly. Cardiff, U.K.
2. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (7-10 October, 2003). Immigration
and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within
mixed biofilm communities. The 2nd international conference of the Royal Jordanian
Medical Services. Amman, Jordan.
3. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (March, 2004). The effects of
chronic exposure to antibiotics upon dynamics in binary biofilms. The 3rd Arab symposium
for antimicrobial agents "Towards Rational use of Antimicrobials. Cairo/Egypt.
4. Amal G. Al- Bakri, Yasser Bustanji, Al-Motassem Yousef (April/2006). Antibacterial
Drug Consumption among the Jordanian Population: Current Status and Future Plans. The
3rd International Conference of the Royal Medical Services in Collaboration with the Royal
college of Physicians of London. Amman, Jordan.
5. Yasser Bustanji, Mutasem Taha, Al-Motassem Yousef, Amal Al- Bakri (2006). Protein
Tyrosine Phosphatase 1B Inhibitors as Potential New Hypoglycemic Agents. The 3rd
International conference of the Royal Jordanian Medical Services. Amman, Jordan.
6. Amal G. Al-Bakri, Motassem Taha and Waleed Zalloum (2007). Bacterial Biofilm and
Resistance: Towards the Discovery of Effective Antibiofilm Agents. The 5th Arab
Symposium for Antimicrobial Agents. Amman, Jordan.
7. Amal G. Al-Bakri, Manal Ayyash and Asem Shehabi (2008). Biofilm associated infections:
control versus resistance. The 6th Arab Conference for Antimicrobial Agents. Rabat-
Morocco
8. Amal G. Al-Bakri Ghadeer Othman and Fatima Afifi (2010). Salvia species as potential
antibiofilm, antiadhesive and anti-MRSA natural agents. The 8th A Arab Conference of
Antimicrobial agents. Syria.
9. Amal G. Al-Bakri (2011). Society’s Failure to Protect the Miracle Drug. Faculty of
Pharmacy-Petra University Scientific Day. Amman-Jordan.
10. Amal G. Al-Bakri, Eman Aqil, Ghadeer Othman and Enam Khalil (2014). Studying the
antimicrobial effect of low energy light activation of photosensitizers on planktonic and
biofilm cultures of Gram negative, Gram positive and Candida albicans.
Conferences: Poster Presentations
1. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (2000). Formation of mixed
species biofilms of Pseudomonas aeruginosa and Burkholderia cepacia, ASM 100th
General Meeting/Los Angeles, California, USA.
2. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (2000). Formation of mixed
species biofilms of Pseudomonas aeruginosa and Burkholderia cepacia, ASM
Conference on "Biofilms 2000". Big Sky, Montana, USA.
3. Amal G. Al- Bakri, Peter Gilbert and David G. Allison (September 2000).
Establishment of Pseudomonas aeruginosa and Burkholderia cepacia binary culture
biofilms. SGM main symposium; Community structure and co-operation in biofilms.
University of Exeter, Exeter, UK.
4. Yasser Bustanji, Mutasem O. Taha, Al-Motassem Yousef Amal G. Al- Bakri (17-21
December, 2005). Berberine Potently Inhibits Protein Tyrosine Phosphatase 1B:
Investigation by Docking Simulation and Experimental Validation. The 9th
International Pharmaceutical Sciences Conference and Exposition.. Riyadh, Kingdom
of Saudi Arabia. Saudi Pharmaceutical Journal 2005, 13(4 S):78.
5. Amal G. Al- Bakri, Yasser Bustanji, Al-Motassem Yousef (April 2006). Community
antibacterial consumption in Jordan: Prudent use or Misuse and Abuse. The 4th Arab
Symposium for Antimicrobial Agents. Tunis, Tunis.
6. Manal Ayyash, Asem Shehabi, A.G. Al-Bakri (May 2008). A novel catheter lock
therapy. Faculty of Pharmacy/UJ Scientific Day. Amman-Jordan.
7. Amal G. Al-Bakri, Hussein Shalan, Atallah Abu-oliem, Nailya Bulatova (2011). A
Prospective randomized controlled trial to investigate the impact of a Clinical
pharmacist on treatment-related problems in patients who receive anti-infective therapy
in the general intensive care unit (ICU) ward of a major medical centre in Jordan.
Faculty of Pharmacy/UJ Scientific Day. Amman-Jordan.
Workshops and Training Courses Attended
1. Teaching and Assessment Methods. (2-December-24 January, 2003). Centre for Educational
Development. Amman, Jordan.
2. Managing Multiple Choice Questions. (3. June, 2003). Centre for Educational Development.
Amman, Jordan.
3. Regional workshop on "Research Approaches and Strategies" (9-12 July, 2003). Held in
collaboration between Wageningen UR, Head of Academic Affairs UNESCO-IHE and Water
and Environment Research and Study Center/University of Jordan. An activity of the
collaborative project of: Capacity building of wastewater valorization for agriculture
production in the Middle East area by using cost effective treatment technology. Amman,
Jordan.
4. Regional workshop on "Training of Trainers" (14-17 July, 2003). Held in collaboration
between Wageningen UR, Head of Academic Affairs UNESCO-IHE and Water and
Environment Research and Study Centre/University of Jordan. An activity of the
collaborative project of: Capacity building of wastewater valorization for agriculture
production in the Middle East area by using cost effective treatment technology. Amman,
Jordan.
5. The Role of Pharmacist (15-16 September 2004). Jordan Food and Drug Administration
Amman, Jordan.
6. Training Human Resources for Quality Assurance Reviewal in the Academic Department
(2004). Quality Assurance Agency (QAA). Amman, Jordan.
7. Training Trainers for Tempus and other Programmes (July, 2005). The consortium of
Universita Cattolica del Sacro Cuore Milan, Ersamus Hogeschool Brussel, European
cultural interactions Athens and the University of Jordan. Supported by the European
Commission DG EAC, within the Tempus-Meda project SCM M007A04. Amman, Jordan.
8. Training course on using Blackboard (2005). King Abdulla II School for Information and
Technology Amman, Jordan.
9. Training course on Recent Techniques for Identification of Bacteria (12-16 March, 2006).
Cairo Mircen, Faculty of Agriculture, Ain Shams University and UNESCO Cairo office.
Cairo, Egypt.
10. Eighth Plenary Meeting of ISO/TC 217- "Cosmetics" and Parallel WG Meetings (15-
19/6/2008). Jordan Standards and Metrology Organisation-Amman, Jordan as a Jordanian
Expert within the following groups
a. ISO/WD 11930 Cosmetics-Microbiology-evaluation of the antimicrobial protection
of a cosmetic product,
b. ISO/CD 29621 "Cosmetics – Microbiology - Guidance factors to the risk assessment
and identification of microbiologically low-risk products"
11. FP7 and the Health Theme (5 July, 2010). The Higher council for science and Technology.
Amman-Jordan.
Memberships
1994-current Jordan Pharmaceutical Association, Jordan.
1997-2003 Biofilm Club, UK.
1999-2001 Society of General Microbiology, U.K.
2000/2001 American Society for Microbiology, USA.
2002-current Arab Alliance for the Prudent Use of Antimicrobial Agents, Egypt.
2004-2005 Faculty representative at the University of Jordan council.
2006-current Jordanian Food and Drug Administration.
2010 Pharmacy Education Accreditation-Higher Education Accreditation Commission-
2007-Sep 2011 Member of the Faculty of Graduate Studies Council
2001-current Member at number of University and Faculty committees
e.g. (Postgraduate, Scientific Research, Library, Equipment and Laboratory, Tender,
Quality Assurance, Study Plan and Curriculum-Ph.D program, and others)
The Chair Person of the Faculty of Pharmacy Scientific Days, 2007 and 2010
Computer Skills and Others
1. The University of Jordan Computer Driving License (UJCDL), passing successfully all of its 9
modules. (Introduction, Windows, Word, Excel, PowerPoint, Access, Internet, Outlook,
FrontPage).
2. Licensed Trainer for Applications to Tempus and other Programmes.
Member in the Editorial Board of
1. The International Arabic Journal of Antimicrobial Agents (IAJAA), 2011
2. TheScientificWorldJOURNAL, 2011
Referee for manuscript published within
1. Jordan Journal of Pharmaceutical Sciences
2. Journal of Pharmaceutical Biology
3. Jordan Journal for Biological Sciences
4. African Journal of Microbiology Research
5. Journal of Essential Oil Bearing Plants
6. Journal of Pharmaceutical Biology
Last Updated 18/02 /2015
Teaching Experience
1. Basic Microbiology
2. Pharmaceutical Microbiology
2. Selected Topics in Pharmaceutical Microbiology
3. Advanced Pharmaceutical Microbiology-MSc
3. Immunology and Genetics
4. Pharmacy Regulations and Ethics
5. Seminar in Pharmaceutics and Pharmaceutical Technology
Quality Control and Assurance experience
1. Pharmacy Education Accreditation:
a. Dean Assistant for Academic Development. Faculty of Pharmacy, University of Jordan for three
years during which the Program Specification and Self Assessment Documents for the Faculty of
Pharmacy had been prepared according to the specifications of Quality Assurance Agency, UK
b. Assessment of Pharmacy Education in Jordan as a committee member of Higher Education
Accreditation Commission
2. Member of the JFDA committee for microbiological labs accreditation. The responsibilities included
a. Inspection of the premises
b. Evaluation of the SOPs
c. Evaluation of the QC and QA
All these require a comprehensive knowledge for all the QC tests that are used to evaluate the
antimicrobial potency of biocides, the preservative efficacy of preservatives, the microbiological quality
of sterile and non sterile drugs, food, water and biocides.
3. Consultant to the Jordan Standards and Metrology Organisation for the revision and the establishment
of SOPs for the Microbiological assessment of Pharmaceuticals and Cosmetics According to ISO
requirement.

Achievements and Awards

1. Ministry of Higher Education B.Sc Scholarship- 1989-1994.
2. Dar Al Dawa- Pharmaceutical Company Ph.D Scholarship, 1997-2001.
3. The University of Jordan Award of Best researcher, Academic Year 2009-2010.
4. The University of Jordan Award of Best Researcher, Academic Year 2010-2011.
4. Marie Marie Curie Actions—International Research Staff Exchange Scheme- IRSES)-FP7, 2010.
5. Daniel Turnberg Fellowship for Medical Sciences, 2011.

  • Marital status :
  • City :
  • Status :
  • Years in active : From To